The World Health Organization is now recommending that countries include an HIV drug newly approved for prevention, ...

Years of American-led investment into AIDS programs has reduced the number of people killed by the disease to the lowest ...

A new U.N. AIDS agency report says the sudden withdrawal of U.S. funding has caused a “systemic shock” to the global effort ...

Austinites impacted by HIV/AIDS have an opportunity to make their needs known at a town hall held by the Austin Area HIV ...

A landmark breakthrough in HIV prevention — a scientific feat decades in the making — received final approval from the Food and Drug Administration last month. Gilead Sciences’ lenacapavir is so effec ...

The WHO issued a global recommendation for lenacapavir, a highly effective, twice-yearly injection to prevent HIV infection.

Years of American-led investment into AIDS programs has reduced the number of people killed by the disease to the lowest ...

Global health leaders and advocates challenged attendees of IAS to support the work of the partnerships that are creating patient-focused innovations for HIV prevention and treatment.

Gilead announced a deal to get its groundbreaking HIV prevention drug to lower income countries. Notably, the deal does not ...

In January the Government of Fiji declared an HIV outbreak in response to the sharp increase in new diagnoses. Although its HIV Surge Strategy seeks to rapidly expand HIV testing and treatment, most ...

The U.S. approved the world's only twice-a-year shot to prevent HIV, the first step in an anticipated rollout that could protect millions globally, but it's unclear how many can get it.